A Yale study links the gut microbiome to multiple sclerosis (MS), revealing that MS patients have distinct bacterial imbalances. Lower levels of IgA-coated bacteria in MS individuals may disrupt immune regulation. These findings suggest that altering gut bacteria could play a role in MS development and lead to potential new treatments.